Clinical Trial Update: Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TNFerade gene therapy in combination with radiation, 5-FU, and cisplatin for esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• TNFerade

Snippet

Sponsor: GenVec | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED